5-127396601-A-G
Variant summary
Our verdict is Uncertain significance. The variant received 3 ACMG points: 3P and 0B. PM2PP3
The NM_001256545.2(MEGF10):c.482A>G(p.Asn161Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000558 in 1,612,190 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001256545.2 missense
Scores
Clinical Significance
Conservation
Publications
- MEGF10-related myopathyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae), ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 3 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001256545.2. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MEGF10 | NM_001256545.2 | MANE Select | c.482A>G | p.Asn161Ser | missense | Exon 6 of 25 | NP_001243474.1 | ||
| MEGF10 | NM_032446.3 | c.482A>G | p.Asn161Ser | missense | Exon 7 of 26 | NP_115822.1 | |||
| MEGF10 | NM_001308119.2 | c.482A>G | p.Asn161Ser | missense | Exon 7 of 15 | NP_001295048.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MEGF10 | ENST00000503335.7 | TSL:1 MANE Select | c.482A>G | p.Asn161Ser | missense | Exon 6 of 25 | ENSP00000423354.2 | ||
| MEGF10 | ENST00000274473.6 | TSL:1 | c.482A>G | p.Asn161Ser | missense | Exon 7 of 26 | ENSP00000274473.6 | ||
| MEGF10 | ENST00000418761.6 | TSL:1 | c.482A>G | p.Asn161Ser | missense | Exon 7 of 15 | ENSP00000416284.2 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152132Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000805 AC: 2AN: 248574 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1460058Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 726188 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152132Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74314 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.482A>G (p.N161S) alteration is located in exon 7 (coding exon 5) of the MEGF10 gene. This alteration results from a A to G substitution at nucleotide position 482, causing the asparagine (N) at amino acid position 161 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
MEGF10-related myopathy Uncertain:1
This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 161 of the MEGF10 protein (p.Asn161Ser). This variant is present in population databases (no rsID available, gnomAD 0.008%). This variant has not been reported in the literature in individuals affected with MEGF10-related conditions. ClinVar contains an entry for this variant (Variation ID: 566235). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at